Stacey Ness, PharmD, MSCS, AAHIVP

Growth hormone deficiency in children and adults is a disease state that utilizes growth hormone therapy. Here is what specialty pharmacists can do for these patients and what they should know about these conditions.

Oncology drug development far outpaces drug development for other therapeutic areas and the magnitude of that difference is significant. Here's a current review of what is in the pipeline and an analysis of where oncology research is headed.

The approval of tofacitinib (Xeljanz) brings a new therapy to the market that could have a big impact on the rheumatoid arthritis treatment paradigm.